Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study


Kucukoglu M. S. , HANTA İ., AKDENİZ B., Gullulu S., Atahan E., SAYIN T., ...More

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.25, no.10, pp.721-732, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 10
  • Publication Date: 2021
  • Doi Number: 10.5152/anatoljcardiol.2021.03009
  • Journal Name: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.721-732
  • Keywords: pulmonary arterial hypertension, iloprost, treatment outcome, safety, survival, COMBINATION THERAPY, ORAL SILDENAFIL, TARGETED DRUGS, NITRIC-OXIDE, PROSTACYCLIN, METAANALYSIS, INSIGHTS
  • Bursa Uludag University Affiliated: Yes

Abstract

Objective: To evaluate clinical efficacy, safety and tolerability of long-term inhaled iloprost treatment in the daily practice for the management of pulmonary arterial hypertension (PAH).